Reference intervals for serum alpha-fetoprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examination Survey

International Journal of Biological Markers

Volumn 26, Issue 1, 2011, Pages 65-71

  Qin, Xue ^a   Lin, Liwen ^a   Mo, Zengnan ^a,b   Lv, Hui ^a   Gao, Yong ^b   Tan, Aihua ^b   Yang, Xiaobo ^b   Li, Shan ^a   Zhao, Jinmin ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Alpha fetoprotein (AFP); Carcinoembryonic antigen (CEA); Reference intervals

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHINESE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; IMMUNOASSAY; MALE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SMOKING;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ALPHA-FETOPROTEINS; CARCINOEMBRYONIC ANTIGEN; CHINA; HEALTH SURVEYS; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; REFERENCE VALUES; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 79953659060     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2011.6364     Document Type: Article

References (40)

1. Sasco AJ. Cancer and globalization. Biomed Pharmacother 2008; 62: 110-21.
2. Ntaios G, Hatzitolios A, Chatzinikolaou A, et al. An audit of tumour marker utilization in Greece. Eur J Intern Med 2009; 20: e66-9.
3. Pissaia A Jr, Bernard D, Scatton O, Soubrane O, Conti F, Calmus Y. Signifcance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation. Transplant Proc 2009; 41: 682-4.
4. Lim YK, Kam MH, Eu KW. Carcinoembryonic antigen screening: how far should we go?. Singapore Med J 2009; 50: 862-5.
5. Gannon CJ, Izzo F, Aloia TA, et al. Can hepatocellular cancer screening increase the proportion of long-term survivors? Hepatogastroenterology 2009; 56: 1152-6.
6. Ren FY, Piao XX, Jin AL. Effcacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12: 4656-9.
7. Fakih MG, Padmanabhan A. CEA monitoring in colorectal cancer. What you should know. Oncology (Williston Park) 2006; 20: 579-87; discussion 588, 594, 596.
8. Erden G, Barazi AO, Tezcan G, Yildirimkaya MM. Biological variation and reference change values of CA 19-9, CEA, AFP in serum of healthy individuals. Scand J Clin Lab Invest 2008; 68: 212-8.
9. Murugavel KG, Mathews S, Jayanthi V, et al. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and afatoxin etiologies. Int J Infect Dis 2008; 12: e71-6.
10. Yi Y, Li B, Wang Z, Sun H, Gong H, Zhang Z. 6534 Cyfra21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal carcinoma. Eur J Cancer Suppl 2009; 7: 371-2.
11. Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol 2005; 11: 645-8.
12. Bjerner J, Høgetveit A, Wold Akselberg K, et al. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specifc enolase (NSE) and CA19.9 from the NORIP study. Scand J Clin Lab Invest 2008; 68: 703-13.
13. Behbehani AI, Mathew A, Farghaly M, van Dalen A. Reference levels of the tumor markers carcinoembryonic antigen, the carbohydrate antigens 19-9 and 72-4, and cytokeratin fragment 19 using the Elecsys Relecsys 1010 analyzer in a normal population in Kuwait. The importance of the determination of local reference levels. Int J Biol Markers 2002; 17: 67-70.
14. Christiansen M, Hogdall CK, Andersen JR, Norgaard-Pedersen B. Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals. Scand J Clin Lab Invest 2001; 61: 205-15.
15. al-Sayer H, al-Bader A, Hussein T, et al. A profle of tumor markers in the population of Kuwait. Anticancer Res 1999; 19: 2369-72.
16. Ball D, Rose E, Alpert E. Alpha-fetoprotein levels in normal adults. Am J Med Sci 1992; 303: 157-9.
17. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 2004; 351: 1548-63.
18. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way?. Am J Clin Pathol 2010; 133: 180-6.
19. Institute CALS. Defning, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. Third edition. CLSI document C28-A3. Wayne: Clinical and Laboratory Standards Institute 2008.
20. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001; 47: 2137-45.
21. Babali A, Cakal E, Purnak T, et al. Serum alpha-fetoprotein levels in liver steatosis. Hepatol Int 2009, Nov 5 [Epub ahead of print].
22. Han Y, Tang Q, Zhu W, Zhang X, You L. Clinical, biochemical, immunological and virological profles of, and differential diagnosis between patients with acute hepatitis B and chronic hepatitis B with acute fare. J Gastroenterol Hepatol 2008; 23: 1728-33.
23. Oyunsuren T, Sanduijav R, Davaadorj D, Nansalmaa D. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Asian Pac J Cancer Prev 2006; 7: 460-2.
24. Gardner RC, Feinerman AE, Kantrowitz PA, Gottblatt S, Loewenstein MS, Zamcheck N. Serial carcinoembryonic antigen (CEA) blood levels in patients with ulcerative colitis. Am J Dig Dis 1978; 23: 129-33.
25. Loewenstein MS, Zamcheck N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 1978; 42: 1412-8.
26. Anonymous. Equivalence between international units and mass units of alpha-foetoprotein. Report of a collaborative study. Clin Chim Acta 1979; 96: 59-65.
27. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009; 46: 8-17.
28. Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett 2010; 293: 133-43.
29. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16: 1321-9.
30. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey SG. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010; 340: c1240.
31. Christiansen M, Andersen JR, Torning J, et al. Serum alpha-fetoprotein and alcohol consumption. Scand J Clin Lab Invest 1994; 54: 215-20.
32. Stevens DP, Mackay IR. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 1973; 2: 1238-9.
33. Alexander JC, Silverman NA, Chretien PB. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 1976; 235: 1975-9.
34. Sajid KM, Parveen R, Durr-e-Sabih, et al. Carcinoembryonic antigen (CEA) levels in hookah smokers, cigarette smokers and non-smokers. J Pak Med Assoc 2007; 57: 595-9.
35. Anisimov VN. Biology of aging and cancer. Cancer Control 2007; 14: 23-31.
36. Anisimov VN, Sikora E, Pawelec G. Relationships between cancer and aging: a multilevel approach. Biogerontology 2009; 10: 323-38.
37. Sizaret P, Martel N, Tuyns A, Reynaud S. Mean alpha-fetoprotein values of 1,333 males over 15 years by age groups. Digestion 1977; 15: 97-103.
38. Beaudonnet A, Gounon G, Pichot J, Revenant MC. Sex-and age-related infuences on carcinoembryonic antigen in blood. Clin Chem 1981; 27: 771.
39. Lahti A, Petersen PH, Boyd JC, Rustad P, Laake P, Solberg HE. Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem 2004; 50: 891-900.
40. Lahti A. Partitioning biochemical reference data into subgroups: comparison of existing methods. Clin Chem Lab Med 2004; 42: 725-33.